Illumina Inc (ILMN) 148.57 $ILMN
SmarTrend Watching for Potential Pullback in Shares of Illumina After 3.42% Gain
Comtex SmarTrend(R) - Mon May 12, 4:47PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $143.50 to a high of $149.75. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $144.90 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of Illumina to Potentially Pullback after Yesterday's 3.42% Rise
Comtex SmarTrend(R) - Mon May 12, 4:46PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $143.50 to a high of $149.75. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $144.90 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Illumina Upgraded to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 1:10PM CDT
On May 10, we upgraded Illumina Inc. (ILMN) to a Zacks Rank #1 (Strong Buy).
Will Patterson (PDCO) Disappoint this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 12:00PM CDT
Patterson's (PDCO) bottom-line growth was on par with the Zacks Consensus Estimate.
Critical Alerts For Amgen, UnitedHealth Group, Yahoo, Anheuser-Busch InBev, and Illumina Released By InvestorsObserver
PR Newswire - Mon May 12, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AMGN, UNH, YHOO, BUD, and ILMN.
Strength Seen in Medivation (MDVN): Stock Up 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:25AM CDT
Medivation (MDVN) was a big mover last session, as the company saw its shares rise nearly 9% on the day.
Webcast Schedules, Clinical Study Results, Stock Price Movements, and Grants - Analyst Notes on Illumina, Questcor, Quest Diagnostics, Raytheon and Lockheed Martin
PR Newswire - Mon May 12, 6:00AM CDT
Today, Analysts Review released its analysts' notes regarding Illumina Inc. (NASDAQ: ILMN), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), Quest Diagnostics Inc. (NYSE: DGX), Raytheon Co. (NYSE: RTN) and Lockheed Martin Corporation (NYSE: LMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2321-100free.
Stock Updates on Health Care Sector Bellwethers -- Research on IMS Health Holdings, Illumina, Novartis, and Zogenix
PR Newswire - Tue May 06, 9:48AM CDT
On Monday, May 05, 2014, the NASDAQ Composite ended at 4,138.06, up 0.34%, the Dow Jones Industrial Average finished the session at 16,530.55, up 0.11% and the S&P 500 closed at 1,884.66, up 0.19%. The gains were broad based as eight out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index ended the day at 672.57, up 0.56%, and the index has advanced 0.12% in the previous one month. Investor-Edge has initiated coverage on the following equities: IMS Health Holdings Inc. (NYSE: IMS), Illumina Inc. (NASDAQ: ILMN), Novartis A.G. (NYSE: NVS) and Zogenix Inc. (NASDAQ: ZGNX). Free technical research on IMS, ILMN, NVS and ZGNX can be downloaded upon signing up at:
Valeant, Tesla Working On Bases As Energy Dominates
at Investor's Business Daily - Mon May 05, 5:34PM CDT
Oil and gas plays continue to dominate this week's Big Cap 20 list, with half the names hailing from the sector. Not surprisingly, most of them have outperformed the market and are extended as a result. But a few other leading nonenergy stocks...
Look for Shares of Illumina to Potentially Pullback after Yesterday's 1.80% Rise
Comtex SmarTrend(R) - Mon May 05, 4:35PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $136.13 to a high of $142.24. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $141.92 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Illumina Rises 1.80% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 05, 4:34PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $136.13 to a high of $142.24. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $141.92 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May and June
Business Wire - Mon May 05, 5:30AM CDT
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company's presentation at three upcoming investment conferences.
Financial Results, Upcoming Earnings Schedules, New Launches, and Lawsuit Filings - Analyst Notes on AstraZeneca, Boston Scientific, Valeant, Illumina and Mylan
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding AstraZeneca PLC (NYSE: AZN), Boston Scientific Corporation (NYSE: BSX), Valeant Pharmaceuticals International, Inc. (NYSE: VRX), Illumina Inc. (NASDAQ: ILMN) and Mylan, Inc. (NASDAQ: MYL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1970-100free.
Illumina Set to Possibly Pullback After Yesterday's Rally of 2.82%
Comtex SmarTrend(R) - Thu May 01, 3:53PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $133.72 to a high of $141.92. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $140.41 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Global Gene Expression Market Technology, Consumables, Services & Applications Report 2014-2019
M2 - Thu May 01, 4:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5nrjl2/gene_expression) has announced the addition of the "Global Gene Expression Market Technology, Consumables, Services & Applications Report 2014-2019" report to their offering. Gene expression analysis has emerged as a major advancement in the fields of drug discovery, diagnostics, and biomedical research. Since the completion of the Human Genome Project in 2003, numerous methods are being developed to improve the efficiency and effectiveness of gene expression profiling and sequencing. it is an important process, as it enables researchers to decipher the functions of genes. By sequencing genes, researchers can determine how diseases affect a cell. Genome-wide analysis can be used to accurately classify diseases. This has led to its increased use in various applications such as pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4%. Increasing number of cancer patients, growth in the number of funding activities, technological advancements, and increased interest in gene expression for research and discovery are the major factors driving the growth of this market. Moreover, various government bodies have extended their help in the form of investments, funds, and grants, which has further stimulated the growth of the market. Life Technologies (U.S.), QIAGEN N.V. (Netherlands), Illumina, Inc. (U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Affymetrix, Inc. (U.S.), GE Healthcare (U.K.), Thermo Fisher Scientific (U.S.), PerkinElmer, Inc. (U.S.), Luminex Corporation (U.S.), and Oxford Gene Technology, Inc. (U.K.) are some of the prominent players in the global market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview - Increasing Number Of Cancer Patients Globally - Increase In Investments, Funds, And Grants By Government Bodies Worldwide - Technological Advancements - Small Rnas Gaining Momentum - Gene Expression Databases To Aid Cancer Research - Use Of Microarray Technology To Aid Gene Expression Studies - Use Of Sbs Technology To Aid More Detailed Cancer Studies - High Cost Of Instruments - Dearth Of Technical Expertise - Rising Opportunities In Emerging Nations - Growth In Personalized Medicine (Gene Therapy) - Sequencing Platforms - Gene Expression Application Market Analysis 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology - DNA Microarrays - Real-Time Polymerase Chain Reaction (Rt-Pcr) - Next Generation Sequencing - Serial Analysis Of Gene Expression (Sage) - Northern Blotting 6 Gene Expression Analysis Consumables Market, By Product - DNA Chips - Oligonucleotides - CDNA - Reagents 7 Gene Expression Analysis Services Market, By Product - Gene Expression Profiling Services - Bioinfomatics Solutions - Data Analysis Software 8 Gene Expression Analysis Market, By Application - Diagnostics - Drug Discovery - Academic Research - Biomarkers - Others 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/5n...expression
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Nucleic Acid Isolation and Purification Market, 2018: Plasmid DNA Isolation, MIRNA Isolation, Total RNA Isolation
M2 - Wed Apr 30, 10:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4fwgw/nucleic_acid) has announced the addition of the "Nucleic Acid Isolation and Purification Market by Technology, Consumables & Instruments, Application & by End Users - Global Forecasts to 2018" report to their offering. The global market is expected to grow at a CAGR of close to 8.11% between 2013 and 2018, to reach $3,106.28 million by 2018. The major players in the nucleic acid isolation and purification market include Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Danaher Corporation (U.S.), Illumina Inc. (U.S.), Life Technologies (U.S.), Promega Corporation (U.S.), Qiagen (Netherlands), Roche Applied Sciences (Germany), and Thermo Fischer Scientific Inc. (U.S.). The technology segment is further divided into column-based, magnetic bead-based, reagent-based, and other (glass fiber and anion exchange) technologies for DNA and RNA isolation and purification. Magnetic-bead technology for DNA isolation is the fastest-growing segment in the nucleic acid isolation and purification technology market. The application segment is further divided into blood DNA isolation and purification, genomic DNA isolation and purification, micro RNA isolation and purification, mRNA isolation and purification, plasmid DNA isolation and purification, total RNA isolation and purification, and PCR cleanup. Micro RNA isolation and purification is expected to grow at the highest CAGR during the forecast period. On the basis of products, the market is classified into consumables and reagents. Consumables dominated the market in 2013. However, the instruments segment is expected to grow in coming future owing to increased applications in hospitals and diagnostics. The end-users market is segmented into academic research, hospitals and diagnostic centers, pharmaceutical and biotech companies, contract research organizations, and others (forensic and food testing laboratories). Academic research accounted for the largest share in this market. However, the hospitals and diagnostic centers segment is expected to grow in the near future owing to the increased applications of nucleic acid testing in molecular diagnostics. The technological advancements and the increased government support in the form of funding are the factors that drive the nucleic acid isolation and purification market across the globe. However, decrease in R&D spending may hinder the growth of this market. The increasing applications of nucleic acid test in molecular diagnostics represent a huge growth opportunity for this market. The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America accounted for a 38.3% share of this market in 2013. However, Asia is expected to grow at a faster rate during the forecast period due to increasing government funding to support life science research. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview - Automation And Technological Innovations To Boost The Adoption Of High Throughput Nucleic Acid Isolation And Purification Instruments - Increased Funding In Life Science Research To Propel The Nucleic Acid Isolation And Purification Market - Increased Application Of Nucleic Acid Testing In Molecular Diagnostics - Increasing Market Consolidation Increases Entry Barriers And Restrains The Market Growth - Low Penetration Of Automated Nucleic Acid Isolation And Purification Kits And Instruments In Emerging Economies - Porter's Five Forces Analysis 5 Global Nucleic Acid Isolation And Purification Market, By Technology - Column-Based Dna Isolation And Purification - Column-Based Rna Isolation And Purification - Magnetic Bead-Based Dna Isolation And Purification - Magnetic Bead-Based Rna Isolation And Purification - Reagent-Based Dna Isolation And Purification - Reagent-Based Rna Isolation And Purification 6 Global Nucleic Acid Isolation And Purification Market, By Application - Blood Dna Isolation And Purification - Genomic Dna Isolation And Purification - Microrna Isolation And Purification - Messenger Rna Isolation And Purification - Pcr Cleanup - Plasmid Dna Isolation And Purification - Total Rna Isolation And Purification 7 Global Nucleic Acid Isolation And Purification Market, By Product 8 Global Nucleic Acid Isolation And Purification Market, By End User - Academic Research Institutes - Hospitals And Diagnostic Centers - Pharmaceutical And Biotechnology Companies - Contract Research Organizations - Others End Users 9 Global Nucleic Acid Isolation And Purification Market, By Geography 10 Competitive Landscape 11 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Ge Healthcare Lifesciences - Illumina, Inc. - Life Technologies Corporation - Promega Corporation - Qiagen - Roche Applied Science - Sigma-Aldrich Co. Llc - Takara Bio, Inc. - Thermo Fischer Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/w4...cleic_acid
Is Illumina (ILMN) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 7:56AM CDT
One such company that might be well-positioned for future earnings growth is Illumina Inc. Not only does it have double digit earnings growth prospect, but its impressive Zacks Rank.
SmarTrend Watching for Potential Pullback in Shares of Illumina After 3.42% Gain
Comtex SmarTrend(R) - Mon May 12, 4:47PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $143.50 to a high of $149.75. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $144.90 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of Illumina to Potentially Pullback after Yesterday's 3.42% Rise
Comtex SmarTrend(R) - Mon May 12, 4:46PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $143.50 to a high of $149.75. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $144.90 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Illumina Upgraded to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 1:10PM CDT
On May 10, we upgraded Illumina Inc. (ILMN) to a Zacks Rank #1 (Strong Buy).
Will Patterson (PDCO) Disappoint this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 12:00PM CDT
Patterson's (PDCO) bottom-line growth was on par with the Zacks Consensus Estimate.
Critical Alerts For Amgen, UnitedHealth Group, Yahoo, Anheuser-Busch InBev, and Illumina Released By InvestorsObserver
PR Newswire - Mon May 12, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AMGN, UNH, YHOO, BUD, and ILMN.
Strength Seen in Medivation (MDVN): Stock Up 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:25AM CDT
Medivation (MDVN) was a big mover last session, as the company saw its shares rise nearly 9% on the day.
Webcast Schedules, Clinical Study Results, Stock Price Movements, and Grants - Analyst Notes on Illumina, Questcor, Quest Diagnostics, Raytheon and Lockheed Martin
PR Newswire - Mon May 12, 6:00AM CDT
Today, Analysts Review released its analysts' notes regarding Illumina Inc. (NASDAQ: ILMN), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), Quest Diagnostics Inc. (NYSE: DGX), Raytheon Co. (NYSE: RTN) and Lockheed Martin Corporation (NYSE: LMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2321-100free.
Stock Updates on Health Care Sector Bellwethers -- Research on IMS Health Holdings, Illumina, Novartis, and Zogenix
PR Newswire - Tue May 06, 9:48AM CDT
On Monday, May 05, 2014, the NASDAQ Composite ended at 4,138.06, up 0.34%, the Dow Jones Industrial Average finished the session at 16,530.55, up 0.11% and the S&P 500 closed at 1,884.66, up 0.19%. The gains were broad based as eight out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index ended the day at 672.57, up 0.56%, and the index has advanced 0.12% in the previous one month. Investor-Edge has initiated coverage on the following equities: IMS Health Holdings Inc. (NYSE: IMS), Illumina Inc. (NASDAQ: ILMN), Novartis A.G. (NYSE: NVS) and Zogenix Inc. (NASDAQ: ZGNX). Free technical research on IMS, ILMN, NVS and ZGNX can be downloaded upon signing up at:
Valeant, Tesla Working On Bases As Energy Dominates
at Investor's Business Daily - Mon May 05, 5:34PM CDT
Oil and gas plays continue to dominate this week's Big Cap 20 list, with half the names hailing from the sector. Not surprisingly, most of them have outperformed the market and are extended as a result. But a few other leading nonenergy stocks...
Look for Shares of Illumina to Potentially Pullback after Yesterday's 1.80% Rise
Comtex SmarTrend(R) - Mon May 05, 4:35PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $136.13 to a high of $142.24. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $141.92 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Illumina Rises 1.80% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 05, 4:34PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $136.13 to a high of $142.24. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $141.92 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May and June
Business Wire - Mon May 05, 5:30AM CDT
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company's presentation at three upcoming investment conferences.
Financial Results, Upcoming Earnings Schedules, New Launches, and Lawsuit Filings - Analyst Notes on AstraZeneca, Boston Scientific, Valeant, Illumina and Mylan
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding AstraZeneca PLC (NYSE: AZN), Boston Scientific Corporation (NYSE: BSX), Valeant Pharmaceuticals International, Inc. (NYSE: VRX), Illumina Inc. (NASDAQ: ILMN) and Mylan, Inc. (NASDAQ: MYL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1970-100free.
Illumina Set to Possibly Pullback After Yesterday's Rally of 2.82%
Comtex SmarTrend(R) - Thu May 01, 3:53PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $133.72 to a high of $141.92. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $140.41 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Global Gene Expression Market Technology, Consumables, Services & Applications Report 2014-2019
M2 - Thu May 01, 4:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5nrjl2/gene_expression) has announced the addition of the "Global Gene Expression Market Technology, Consumables, Services & Applications Report 2014-2019" report to their offering. Gene expression analysis has emerged as a major advancement in the fields of drug discovery, diagnostics, and biomedical research. Since the completion of the Human Genome Project in 2003, numerous methods are being developed to improve the efficiency and effectiveness of gene expression profiling and sequencing. it is an important process, as it enables researchers to decipher the functions of genes. By sequencing genes, researchers can determine how diseases affect a cell. Genome-wide analysis can be used to accurately classify diseases. This has led to its increased use in various applications such as pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4%. Increasing number of cancer patients, growth in the number of funding activities, technological advancements, and increased interest in gene expression for research and discovery are the major factors driving the growth of this market. Moreover, various government bodies have extended their help in the form of investments, funds, and grants, which has further stimulated the growth of the market. Life Technologies (U.S.), QIAGEN N.V. (Netherlands), Illumina, Inc. (U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Affymetrix, Inc. (U.S.), GE Healthcare (U.K.), Thermo Fisher Scientific (U.S.), PerkinElmer, Inc. (U.S.), Luminex Corporation (U.S.), and Oxford Gene Technology, Inc. (U.K.) are some of the prominent players in the global market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview - Increasing Number Of Cancer Patients Globally - Increase In Investments, Funds, And Grants By Government Bodies Worldwide - Technological Advancements - Small Rnas Gaining Momentum - Gene Expression Databases To Aid Cancer Research - Use Of Microarray Technology To Aid Gene Expression Studies - Use Of Sbs Technology To Aid More Detailed Cancer Studies - High Cost Of Instruments - Dearth Of Technical Expertise - Rising Opportunities In Emerging Nations - Growth In Personalized Medicine (Gene Therapy) - Sequencing Platforms - Gene Expression Application Market Analysis 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology - DNA Microarrays - Real-Time Polymerase Chain Reaction (Rt-Pcr) - Next Generation Sequencing - Serial Analysis Of Gene Expression (Sage) - Northern Blotting 6 Gene Expression Analysis Consumables Market, By Product - DNA Chips - Oligonucleotides - CDNA - Reagents 7 Gene Expression Analysis Services Market, By Product - Gene Expression Profiling Services - Bioinfomatics Solutions - Data Analysis Software 8 Gene Expression Analysis Market, By Application - Diagnostics - Drug Discovery - Academic Research - Biomarkers - Others 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/5n...expression
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Nucleic Acid Isolation and Purification Market, 2018: Plasmid DNA Isolation, MIRNA Isolation, Total RNA Isolation
M2 - Wed Apr 30, 10:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4fwgw/nucleic_acid) has announced the addition of the "Nucleic Acid Isolation and Purification Market by Technology, Consumables & Instruments, Application & by End Users - Global Forecasts to 2018" report to their offering. The global market is expected to grow at a CAGR of close to 8.11% between 2013 and 2018, to reach $3,106.28 million by 2018. The major players in the nucleic acid isolation and purification market include Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Danaher Corporation (U.S.), Illumina Inc. (U.S.), Life Technologies (U.S.), Promega Corporation (U.S.), Qiagen (Netherlands), Roche Applied Sciences (Germany), and Thermo Fischer Scientific Inc. (U.S.). The technology segment is further divided into column-based, magnetic bead-based, reagent-based, and other (glass fiber and anion exchange) technologies for DNA and RNA isolation and purification. Magnetic-bead technology for DNA isolation is the fastest-growing segment in the nucleic acid isolation and purification technology market. The application segment is further divided into blood DNA isolation and purification, genomic DNA isolation and purification, micro RNA isolation and purification, mRNA isolation and purification, plasmid DNA isolation and purification, total RNA isolation and purification, and PCR cleanup. Micro RNA isolation and purification is expected to grow at the highest CAGR during the forecast period. On the basis of products, the market is classified into consumables and reagents. Consumables dominated the market in 2013. However, the instruments segment is expected to grow in coming future owing to increased applications in hospitals and diagnostics. The end-users market is segmented into academic research, hospitals and diagnostic centers, pharmaceutical and biotech companies, contract research organizations, and others (forensic and food testing laboratories). Academic research accounted for the largest share in this market. However, the hospitals and diagnostic centers segment is expected to grow in the near future owing to the increased applications of nucleic acid testing in molecular diagnostics. The technological advancements and the increased government support in the form of funding are the factors that drive the nucleic acid isolation and purification market across the globe. However, decrease in R&D spending may hinder the growth of this market. The increasing applications of nucleic acid test in molecular diagnostics represent a huge growth opportunity for this market. The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America accounted for a 38.3% share of this market in 2013. However, Asia is expected to grow at a faster rate during the forecast period due to increasing government funding to support life science research. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview - Automation And Technological Innovations To Boost The Adoption Of High Throughput Nucleic Acid Isolation And Purification Instruments - Increased Funding In Life Science Research To Propel The Nucleic Acid Isolation And Purification Market - Increased Application Of Nucleic Acid Testing In Molecular Diagnostics - Increasing Market Consolidation Increases Entry Barriers And Restrains The Market Growth - Low Penetration Of Automated Nucleic Acid Isolation And Purification Kits And Instruments In Emerging Economies - Porter's Five Forces Analysis 5 Global Nucleic Acid Isolation And Purification Market, By Technology - Column-Based Dna Isolation And Purification - Column-Based Rna Isolation And Purification - Magnetic Bead-Based Dna Isolation And Purification - Magnetic Bead-Based Rna Isolation And Purification - Reagent-Based Dna Isolation And Purification - Reagent-Based Rna Isolation And Purification 6 Global Nucleic Acid Isolation And Purification Market, By Application - Blood Dna Isolation And Purification - Genomic Dna Isolation And Purification - Microrna Isolation And Purification - Messenger Rna Isolation And Purification - Pcr Cleanup - Plasmid Dna Isolation And Purification - Total Rna Isolation And Purification 7 Global Nucleic Acid Isolation And Purification Market, By Product 8 Global Nucleic Acid Isolation And Purification Market, By End User - Academic Research Institutes - Hospitals And Diagnostic Centers - Pharmaceutical And Biotechnology Companies - Contract Research Organizations - Others End Users 9 Global Nucleic Acid Isolation And Purification Market, By Geography 10 Competitive Landscape 11 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Ge Healthcare Lifesciences - Illumina, Inc. - Life Technologies Corporation - Promega Corporation - Qiagen - Roche Applied Science - Sigma-Aldrich Co. Llc - Takara Bio, Inc. - Thermo Fischer Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/w4...cleic_acid
Is Illumina (ILMN) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 7:56AM CDT
One such company that might be well-positioned for future earnings growth is Illumina Inc. Not only does it have double digit earnings growth prospect, but its impressive Zacks Rank.
